Maximus, Inc. (NYSE:MMS – Get Free Report) insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Maximus Stock Up 0.1 %
Shares of MMS stock opened at $74.67 on Thursday. The stock has a 50 day moving average of $85.47 and a 200-day moving average of $87.32. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The firm has a market cap of $4.50 billion, a PE ratio of 14.93 and a beta of 0.73. Maximus, Inc. has a 12 month low of $71.75 and a 12 month high of $93.97.
Maximus Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.61%. The ex-dividend date was Friday, November 15th. Maximus’s dividend payout ratio (DPR) is presently 24.00%.
Institutional Investors Weigh In On Maximus
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th.
Get Our Latest Analysis on MMS
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- Consumer Staples Stocks, Explained
- 2 AI-Powered Platforms Disrupting the Finance Industry
- What is the Hang Seng index?
- Tesla Poised to Hit Record Highs This Holiday Season
- 3 Best Fintech Stocks for a Portfolio Boost
- The Salesforce Rally is Just Getting Started: Here’s Why
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.